BioPharma Dive July 29, 2024
The deal follows similar alliances Pfizer and Novo Nordisk have struck to tap into the venture firm’s portfolio of startup companies.
Dive Brief:
- GSK is the latest pharmaceutical company to form a drug-hunting partnership with Flagship Pioneering, announcing Monday a deal to tap the startup incubator’s portfolio to find new medicines and vaccines.
- Flagship and GSK have committed up to $150 million to fund the effort, through which the British drugmaker hopes to find up to 10 new medicines or shots. GSK will have an exclusive option to license those prospects, with Flagship and its startups eligible for up to $720 million in milestone payments per program, as well as unspecified preclinical funding and sales royalties.
- The deal closely...
Today's Sponsors
Today's Sponsor